ALK-Abello AS - Company Profile

Powered by

All the data and insights you need on ALK-Abello AS in one report.

  • Save hours of research time and resources with
    our up-to-date ALK-Abello AS Strategy Report

  • Understand ALK-Abello AS position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

ALK-Abello AS: Segment Analysis

Business Description

ALK-Abello AS (ALK), a subsidiary of The Lundbeck Foundation, discovers and develops drugs targeting the cause of allergies. The company carries out its operations through a single business segment: Allergy treatment.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

ALK’s research and development (R&D) team focuses on the development of new, evidence-based SLIT tablets. The company’s tablet-based vaccine pipeline covers five major respiratory allergies: grass pollen, tree pollen, ragweed pollen, house dust mites, and Japanese cedar. The product pipeline of the company includes HDM SLIT tablet, Peanut SLIT-tablet (North America and Europe), Tree SLIT tablet (Europe), and Japanese cedar SLIT tablet. ALK focuses on two pediatric trials for ACARIZAX/ODACTRA in Europe and the US for allergic rhinitis and allergic asthma. ALK focuses on developing new, mainstream treatments for food allergy. In FY2023, the company spent DKK618 million on R&D, which as a percentage of revenue stood at 12.8%.


Product Categories

Overview

Other products of the company include allergy emergency treatment and allergy diagnostics. Major product is Jext, an adrenaline auto-injector (AAI).

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Overview

SCIT is an injection-based allergy vaccine. It prevents respiratory allergies from grass and tree pollen, house dust mites, and animal dander. It also acts as a preventer of severe allergic reactions due to insect stings. It offers these products in Europe and North America. SLIT drops are administered as droplets under the tongue. It offers this product in France.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Overview

ALK’s tablet for grass allergy is commercialized in Europe under the trade name Grazax, and in North America under the trade name Grastek. Ragwitek for ragweed allergic rhinitis, is available in North America. Its other products include Miticure for house dust mite allergic rhinitis in Japan; Odactra in the US; and Acarizax for house dust mite allergic rhinitis and allergic asthma in Europe.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Gain a 360-degree view of ALK-Abello AS and make more informed decisions for your business Gain a 360-degree view of ALK-Abello AS and make more informed decisions for your business Find out more


Geographical Segments

Target Markets

Comprises the EU, Switzerland, and Norway.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Target Markets

Comprises Japan, China, and other countries.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Target Markets

Comprises Canada and the USA.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Gain a 360-degree view of ALK-Abello AS and make more informed decisions for your business Gain a 360-degree view of ALK-Abello AS and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward